In order to study the importance of cutaneous blood flow variations to percutaneous drug absorption and local distribution, a bipediculated dorsal flap was created in the hairless rat. This model allowed us to compare the percutaneous drug absorption on both sides of the flap, one with normal blood flow and the other with a reproducible blood flow decrease (60%) obtained by ligation of one pedicle. 14C-labelled compounds, progesterone (lipophilic), caffeine (amphiphilic) and urea (hydrophilic) were applied in ethanolic solution during 4 h on the two sides of the flap. When the cutaneous blood flow was lowered, the skin radioactivity increased greatly for caffeine (76% in superficial dermis, 67% in deep dermis), less for progesterone (37% in superficial dermis, 30% in deep dermis). For urea, no significant difference was observed between the two sides of the flap. Nevertheless, when the absorption of urea was promoted by application on stripped skin, radioactivity was greatly increased on the ligated side of the flap (240% in superficial dermis, 423% in deep dermis). Our results showed that a hydrophilic compound poorly absorbed (urea) was insensitive to cutaneous blood flow modifications whereas compounds readily absorbed (caffeine, amphiphilic; urea on stripped skin) or slightly absorbed (progesterone, lipophilic) exhibited local concentration phenomena in relation to cutaneous blood flow lowering.

Keywords:
Percutaneous absorption, Caffeine, Progesterone, Urea, Skin flap, Cutaneous blood flow
This content is only available via PDF.
© 1991 S. Karger AG, Basel
1991
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.